Intronbio, new VRE drug ‘EFL2200’ confirms broad spectrum antibacterial efficacy
Today’s Money Reporter Kim Do-yoon | 2023.06.19 11:08 Intron Bio announced on the 19th that it has confirmed the broad-spectrum antibacterial efficacy of ‘EFL2200’, a new bio-drug targeting VRE (Vancomycin-resistant Enterococci). VRE is one of the resistant bacteria that poses a serious threat to human health, warned by the US Centers for Disease Control and […]
